Source: Eur Respir J 2016; 48: 1710-1720
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Chad A. Newton, Kiran Batra, Jose Torrealba, Julia Kozlitina, Craig S. Glazer, Carlos Aravena, Keith Meyer, Ganesh Raghu, Harold R. Collard, Christine Kim Garcia. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J 2016; 48: 1710-1720

Member's Comments

No comment yet.

Related content which might interest you: Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function Source: Eur Respir J 2002; 20: Suppl. 38, 209s Year: 2002 Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (5) 1801138; 10.1183/13993003.01138-2018 Year: 2018 Alveoscopy in diffuse interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 244s Year: 2007 Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Genotype and progressive lung damage in adult cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 502s Year: 2003 How to diagnose cystic interstitial lung disease Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease Year: 2015 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002 Radiology in diffuse parenchymal lung disease and lung nodules Source: Eur Respir Rev, 26 (144) 170049; 10.1183/16000617.0049-2017 Year: 2017 A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 32: 170-174 Year: 2008 Diffuse parenchymal lung disease Source: International Congress 2016 – Clinical year in review Year: 2016 Diffuse parenchymal lung disease Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017 Year: 2017 Lung clearance index is reproducible and close to normal in stable cystic fibrosis patients post bilateral lung transplant Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014